GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abbisko Cayman Ltd (HKSE:02256) » Definitions » Price-to-Owner-Earnings

Abbisko Cayman (HKSE:02256) Price-to-Owner-Earnings : 119.75 (As of May. 31, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Abbisko Cayman Price-to-Owner-Earnings?

As of today (2025-05-31), Abbisko Cayman's share price is HK$9.58. Abbisko Cayman's Owner Earnings per Share (TTM) ended in Dec. 2024 was HK$0.08. It's Price-to-Owner-Earnings for today is 119.75.


The historical rank and industry rank for Abbisko Cayman's Price-to-Owner-Earnings or its related term are showing as below:

HKSE:02256' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 57.14   Med: 93.7   Max: 124.42
Current: 124.42

During the past 6 years, the highest Price-to-Owner-Earnings of Abbisko Cayman was 124.42. The lowest was 57.14. And the median was 93.70.


HKSE:02256's Price-to-Owner-Earnings is ranked worse than
87.08% of 178 companies
in the Biotechnology industry
Industry Median: 28.765 vs HKSE:02256: 124.42

As of today (2025-05-31), Abbisko Cayman's share price is HK$9.58. Abbisko Cayman's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.05. Therefore, Abbisko Cayman's PE Ratio (TTM) for today is 212.89.

As of today (2025-05-31), Abbisko Cayman's share price is HK$9.58. Abbisko Cayman's EPS without NRI for the trailing twelve months (TTM) ended in was HK$0.05. Therefore, Abbisko Cayman's PE Ratio without NRI for today is 212.89.

During the past 6 years, Abbisko Cayman's highest PE Ratio without NRI was 222.79. The lowest was 102.33. And the median was 167.79.


Abbisko Cayman Price-to-Owner-Earnings Historical Data

The historical data trend for Abbisko Cayman's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbisko Cayman Price-to-Owner-Earnings Chart

Abbisko Cayman Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Owner-Earnings
Get a 7-Day Free Trial - - - - 59.87

Abbisko Cayman Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 59.87

Competitive Comparison of Abbisko Cayman's Price-to-Owner-Earnings

For the Biotechnology subindustry, Abbisko Cayman's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbisko Cayman's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Abbisko Cayman's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Abbisko Cayman's Price-to-Owner-Earnings falls into.


;
;

Abbisko Cayman Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Abbisko Cayman's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=9.58/0.08
=119.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abbisko Cayman  (HKSE:02256) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Abbisko Cayman Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Abbisko Cayman's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbisko Cayman Business Description

Traded in Other Exchanges
Address
Building 3, No. 898 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, CHN
Abbisko Cayman Ltd is an investment holding company that operates through its subsidiaries which is a clinical-stage biopharmaceutical company dedicated to the discovery and development of medicines and differentiated small molecule oncology therapies. The company has only one business segment which is the development of medicines.
Executives
Xu Yao-chang 2101 Beneficial owner
Qiming Corporate Gp Vi, Ltd. 2201 Interest of corporation controlled by you
Yu Hongping 2501 Other
Chen Zhui 2501 Other
Lav Asset Management (hong Kong) Limited 2102 Investment manager
Shi Yi 2201 Interest of corporation controlled by you
Trident Trust Company (hk) Limited 2301 Trustee
Futu Trustee Limited 2301 Trustee
Temasek Holdings (private) Limited 2201 Interest of corporation controlled by you
Yu Hongping 2501 Other
Morgan Stanley 2201 Interest of corporation controlled by you
Temasek Life Sciences Private Limited
Computershare Hong Kong Trustees Limited 2301 Trustee
Morgan Stanley Investments (uk) 2201 Interest of corporation controlled by you
Morgan Stanley International Limited 2201 Interest of corporation controlled by you

Abbisko Cayman Headlines

No Headlines